Enavate Sciences GP, LLC Long-Term Concentrated

Location: New York, NY

CIK: 0001953107 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 17, 2026

Total Value: $507M (100.0% shares, 0.0% debt)

Holdings (7)

ZBIO ZENAS BIOPHARMA INC 28.1%

Value $142M Shares 3,919,159 Est. Cost $16.29 Unrealized +101.8%

IMNM IMMUNOME INC 20.2%

Value $102M Shares 4,768,583 Est. Cost $11.41 Unrealized +53.8%

SION SIONNA THERAPEUTICS INC 20.1%

Value $102M Shares 2,478,030 Est. Cost $16.34 Unrealized +132.1%

UPB UPSTREAM BIO INC 13.2%

Value $66.78M Shares 2,459,703 Est. Cost $22.33 Unrealized +11.5%

CMPX COMPASS THERAPEUTICS INC 8.3%

Value $41.82M Shares 7,788,150 Est. Cost $1.66 Unrealized +178.1%

BBOT BRIDGEBIO ONCOLOGY THERAPEUT 6.5%

Value $32.89M Shares 2,626,946 Est. Cost $11.58 Unrealized —

CAMP CAMP4 THERAPEUTICS CORP 3.7%

Value $18.61M Shares 3,035,825 Est. Cost $8.22 Unrealized -48.2%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ZBIO	ZENAS BIOPHARMA INC	3,919,159	$142M	28.1%	$16.29	+101.8%	COM	98937L105
IMNM	IMMUNOME INC	4,768,583	$102M	20.2%	$11.41	+53.8%	COM	45257U108
SION	SIONNA THERAPEUTICS INC	2,478,030	$102M	20.1%	$16.34	+132.1%	COM	829401108
UPB	UPSTREAM BIO INC	2,459,703	$66.78M	13.2%	$22.33	+11.5%	COM	91678A107
CMPX	COMPASS THERAPEUTICS INC	7,788,150	$41.82M	8.3%	$1.66	+178.1%	COM	20454B104
BBOT	BRIDGEBIO ONCOLOGY THERAPEUT	2,626,946	$32.89M	6.5%	$11.58	—	COM NEW	107924102
CAMP	CAMP4 THERAPEUTICS CORP	3,035,825	$18.61M	3.7%	$8.22	-48.2%	COM	13463J101